Zoetis Inc. (BMV:ZTS)

Mexico flag Mexico · Delayed Price · Currency is MXN
2,196.00
-32.00 (-1.44%)
At close: Dec 4, 2025
-38.31%
Market Cap 951.34B
Revenue (ttm) 172.36B
Net Income (ttm) 48.63B
Shares Out n/a
EPS (ttm) 108.89
PE Ratio 19.56
Forward PE 18.06
Dividend 38.78 (1.77%)
Ex-Dividend Date Oct 31, 2025
Volume 48
Average Volume 867
Open 2,227.00
Previous Close 2,228.00
Day's Range 2,196.00 - 2,227.00
52-Week Range 2,130.00 - 3,629.81
Beta n/a
RSI 32.86
Earnings Date Feb 13, 2026

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 13,800
Stock Exchange Mexican Stock Exchange
Ticker Symbol ZTS
Full Company Profile

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD Financial Statements

News

There is no news available yet.